Drug based on red wine might curb obesity and diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking SRT1720, a drug by GlaxoSmithKline unit Sirtris, did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The compound, based on red wine extract resveratrol, also extended the life of mice eating junk food by as much as 44%. Three similar drugs are undergoing clinical tests in humans.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD